Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-008531

Options or other derivatives

  • Chief Financial Officer acquired 94,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Davis Blaine Chief Financial Officer 2020-02-11 Grant or award · Stock Option (Right to Buy) +94,000 94,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…